title: The authors reply.
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Harr
authors.forename: Ernest E
authors.initials: EE
authors.lastname: Moore
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Johnson
authors.forename: Theresa L
authors.initials: TL
authors.lastname: Chin
authors.forename: Max V
authors.initials: MV
authors.lastname: Wohlauer
authors.forename: Anirban
authors.initials: A
authors.lastname: Banerjee
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Silliman
authors.forename: Angela
authors.initials: A
authors.lastname: Sauaia
mesh_terms: D055371:Acute Lung Injury / Q000453:epidemiology*; D001803:Blood Transfusion / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D009102:Multiple Organ Failure / Q000453:epidemiology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014947:Wounds and Injuries / Q000401:mortality*
chemical_list: D010975:Platelet Aggregation Inhibitors